The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25280182 |
3 |
DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development. |
Central University of Punjab |
| 23859074 |
189 |
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II. |
University of Manchester |
| 22455312 |
43 |
Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors. |
National Center For Advancing Translational Sciences |
| 20067291 |
20 |
Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1). |
Purdue University |
| 30653918 |
44 |
Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1. |
Boston University |
| 28161249 |
55 |
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1). |
Russian Academy of Sciences |
| 19874209 |
11 |
New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation. |
University of Orleans |
| 7562467 |
11 |
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018. |
Upjohn Pharmaceuticals |
| 7523657 |
14 |
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. |
Eli Lilly |
| 19128971 |
22 |
Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS. |
Cytopia Research |
Search and Browse
